Circulating Tissue Inhibitor of Matrix Metalloproteinase-4 (TIMP-4) in Systemic Sclerosis Patients with Elevated Pulmonary Arterial Pressure
Decreased levels of matrix metalloproteinases (MMPs) or excess levels of their tissue inhibitors (TIMPs) may contribute to dysregulation of extracellular matrix turnover in systemic sclerosis (SSc). In a cross-sectional study of 106 SSc patients, we measured serum levels of TIMP-4 which is preferen...
Saved in:
Main Authors: | Gialafos J. Elias, Moyssakis Ioannis, Psaltopoulou Theodora, Papadopoulos P. Dimitrios, Perea Despoina, Vlasis Kostantinos, Kostopoulos Charalampos, Votteas Vassilios, Sfikakis P. Petros |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2008/164134 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploratory study of nocebo effect in senior medical students
by: Charalampos Pischos, et al.
Published: (2024-05-01) -
Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus
by: Lucia Saucedo, et al.
Published: (2021-01-01) -
Timp2 loss-of-function mutation and TIMP2 treatment in a murine model of NSCLC: Modulation of immunosuppression and oncogenic signaling
by: David Peeney, et al.
Published: (2025-03-01) -
Matrix Metalloproteinases in patients with Multiple Sclerosis.
by: Rebeca A. Fernández Carriera, et al.
Published: (2007-05-01) -
MMP-2 and MMP-9 Activities and TIMP-1 and TIMP-2 Expression in the Prostatic Tissue of Two Ethanol-Preferring Rat Models
by: Beatriz Aparecida Fioruci-Fontanelli, et al.
Published: (2015-01-01)